Comparison of patient characteristics and outcome between a single-institution phase II trial and a cooperative-group phase II trial with identical eligibility in metastatic melanoma.

Source:http://linkedlifedata.com/resource/pubmed/id/9391549

Download in:

View as

General Info

PMID
9391549